Rémi Tilmont

Mechanisms of antigen escape from BCMA- or GPRC5D-targeted immunotherapies in multiple myeloma

Holly Lee, Sungwoo Ahn, Ranjan Maity et al. · Nature Medicine · 2023 · 318 citations · Full text

Life Sciences, Immunology, Oncology +15

Integrated epigenetic and transcriptional single-cell analysis of t(11;14) multiple myeloma and its BCL2 dependency

Noémie Leblay, Sungwoo Ahn, Rémi Tilmont et al. · Blood · 2023 · 32 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +17

ETV4-Dependent Transcriptional Plasticity Maintains <i>MYC</i> Expression and Results in IMiD Resistance in Multiple Myeloma

Paola Neri, Benjamin G. Barwick, David Jung et al. · Blood Cancer Discovery · 2023 · 31 citations · Full text

Medicine, Cancer Biology, Oncology +17

The Impact of Soluble BCMA and BCMA Gain on Anti-BCMA Immunotherapies in Multiple Myeloma

Holly Lee, Michael Durante, Sungwoo Ahn et al. · Blood · 2023 · 14 citations

Medicine, Immunology, Oncology +12

Myeloid neoplasms after CD19-directed CAR T cells therapy in long-term B-cell lymphoma responders, a rising risk over time?

Nicolas Gazeau, David Beauvais, Rémi Tilmont et al. · Leukemia · 2025 · 14 citations · Full text

Medicine, Hematology, Oncology +17